Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Marinus Pharmaceuticals Q3 EPS $1.89 Up From $(0.53) YoY

Marinus Pharmaceuticals (NASDAQ:MRNS) reported quarterly earnings of $1.89 per share. This is a 456.6 percent increase over losses of $(0.53) per share from the same period last year.
byBenzinga Newsdesk
November 7, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Marinus Pharmaceuticals (NASDAQ:MRNS) reported quarterly earnings of $1.89 per share. This is a 456.6 percent increase over losses of $(0.53) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Australia Calls For Inquiry Into Meta’s Facebook, Elon Musk’s X, TikTok To ‘Make These Platforms Accountable For Their Decisions’

By Benzinga Neuro
May 9, 11:45 PM
The Australian government has expressed concerns over the lack of regulation and oversight on social media platforms, which have a significant impact on the content viewed by Australians. The inquiry will specifically focus on the platforms' handling of violent content and their withdrawal from paying for news in Australia.

META